Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

280 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adverse drug reaction reporting by patients in the Netherlands: three years of experience.
de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. de Langen J, et al. Drug Saf. 2008;31(6):515-24. doi: 10.2165/00002018-200831060-00006. Drug Saf. 2008. PMID: 18484785
Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
Crijns I, Mantel-Teeuwisse A, Bloemberg R, Pinas E, Straus S, de Jong-van den Berg L. Crijns I, et al. Expert Opin Drug Saf. 2013 Jan;12(1):29-38. doi: 10.1517/14740338.2013.745850. Epub 2012 Nov 20. Expert Opin Drug Saf. 2013. PMID: 23163396
Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.
Crijns I, Straus S, Luteijn M, Gispen-de Wied C, Raine J, de Jong-van den Berg L. Crijns I, et al. Drug Saf. 2012 Jan 1;35(1):27-32. doi: 10.2165/11595570-000000000-00000. Drug Saf. 2012. PMID: 22050373
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.
van Hunsel F, Talsma A, van Puijenbroek E, de Jong-van den Berg L, van Grootheest K. van Hunsel F, et al. Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):286-91. doi: 10.1002/pds.2092. Epub 2010 Dec 28. Pharmacoepidemiol Drug Saf. 2011. PMID: 21351310
Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.
van Hunsel F, van Puijenbroek E, de Jong-van den Berg L, van Grootheest K. van Hunsel F, et al. Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):26-32. doi: 10.1002/pds.1865. Pharmacoepidemiol Drug Saf. 2010. PMID: 19953500
Patients' role in reporting adverse drug reactions.
van Grootheest K, de Jong-van den Berg L. van Grootheest K, et al. Expert Opin Drug Saf. 2004 Jul;3(4):363-8. doi: 10.1517/14740338.3.4.363. Expert Opin Drug Saf. 2004. PMID: 15268652 Review.
Pharmacists' role in reporting adverse drug reactions in an international perspective.
van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. van Grootheest K, et al. Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):457-64. doi: 10.1002/pds.897. Pharmacoepidemiol Drug Saf. 2004. PMID: 15269929
A comparison of pregnancy prevention programmes in Europe.
Crijns I, Zomerdijk I, Sturkenboom M, de Jong-van den Berg L, Straus S. Crijns I, et al. Expert Opin Drug Saf. 2014 Apr;13(4):411-20. doi: 10.1517/14740338.2014.887678. Epub 2014 Feb 8. Expert Opin Drug Saf. 2014. PMID: 24506812
Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions.
Charlton R, Garne E, Wang H, Klungs√łyr K, Jordan S, Neville A, Pierini A, Hansen A, Engeland A, Gini R, Thayer D, Bos J, Puccini A, Nybo Andersen AM, Dolk H, de Jong-van den Berg L. Charlton R, et al. Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1144-54. doi: 10.1002/pds.3847. Epub 2015 Aug 13. Pharmacoepidemiol Drug Saf. 2015. PMID: 26272314
Paternal drug use: before and during pregnancy.
Crijns I, Bos J, Knol M, Straus S, de Jong-van den Berg L. Crijns I, et al. Expert Opin Drug Saf. 2012 Jul;11(4):513-8. doi: 10.1517/14740338.2012.674109. Epub 2012 Mar 23. Expert Opin Drug Saf. 2012. PMID: 22439857
280 results
Jump to page
Feedback